[1] Baldursdottir TR,Bergmann OM,Jonasson JG,et al. The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study. Eur J Gastroenterol Hepatol,2012, 24: 824-830.
[2] Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol, 2012, 56: 1181-1188.
[3] Lee TP, Chiang BL. Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun Rev, 2012, 11: A422-429.
[4] Caiazza F, Ryan EJ, Doherty G, et al. Estrogen receptors and their implications in colorectal carcinogenesis. Front Oncol, 2015, 5: 19.
[5] Procaccini NJ, Kowdley KV. Editorial: improved understanding of the epidemiology of primary biliary cirrhosis in South Korea. Aliment PharmacolTher, 2016, 43: 650-651.
[6] Kim KA, Ki M, Choi HY, et al. Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther, 2016, 43:154-162.
[7] Zhang B, Wu ZY. Estrogen derivatives: novel therapeutic agents for liver cirrhosis and portal hypertension. Eur J Gastroenterol Hepatol, 2013, 25: 263-270.
[8] Hughes GC,Martin D,Zhang K,et al.Decrease in glomerulonephritis and Thl-associated autoantibody production after progesterone treatment in NZB /NZW mice.Arthritis Rh eum.2009,60:1775-1784.
[9] Morii K, Nishisaka M, Nakamura S, et al. A case of synthetic oestrogen-induced autoimmune hepatitis with microvesicular steatosis. J Clin Pharm Ther, 2014, 39: 573-576.
[10] Zhang G, Zhou Y, Rao Z, et al. Effect of in-Zhi-Huang on up-regulation of Oatp2, Ntcp, and Mrp2 proteins in estrogen-induced rat cholestasis. PharmBiol, 2015, 53: 319-325.
[11] Pan X, Jeong H. Estrogen-Induced Cholestasis Leads to Repressed CYP2D6 Expression in CYP2D6-Humanized Mice. Mol Pharmacol, 2015, 88:106-112.
[12] Chen J, Zhao KN, Liu GB. Estrogen-induced cholestasis: pathogenesis and therapeuticimplications. Hepatogastroenterology, 2013, 60: 1289-1296.
[13] 施杰民, 陈洁, 李莉, 等. 雌激素对原发性胆汁性肝硬化自身免疫反应影响的研究进展. 中华临床医师杂志(电子版), 2010, 4:314-317.
[14] Song X, Vasilenko A, Chen Y, et al. Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepaticcholestasis of pregnancy. Hepatology, 2014, 60: 1993-2007.
[15] Kim KA, Jeong SH. The diagnosis and treatment of primary biliary cirrhosis. Korean J hepatol, 2011, 17:173-179.
[16] Wang J, Yang G, Dubrovsky AM, et al. Xenobiotics and loss of tolerance in primary biliary cholangitis. World J Gastroenterol, 2016, 22: 338-348.
[17] Juran BD, Lazaridis KN. Enviromental factors in primary biliary cirrhosis. Semin Liver Dis, 2014, 34: 265272.
[18] Hirschfield GM, Gershwin ME. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol, 2013, 24: 303-330.
[19] Selmi C,Diana A,Cocchi CA,et al.Environmental factors and the induction of autoimmunity in primary biliary cirrhosis. Expert Rev ClinImmunol, 2014,4: 239-245.
[20] Allina J, Stanca CM, Garber J, et al. Anti-CD 16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun, 2008, 30: 238-245.
[21] Hu B, Allina J, Bai J, et al. Catalase and estradiol inhibit mitochondrial protein S-glutathionylation. Mol Cell Biochem, 2012, 367: 51-58.
[22] Boone RH, Cheung AM, Girlan LM. Osteoporosis in primary cirrhosis: A randomized trial of the efficacy and feasibility of estrogen/progestin. Dig Dis Sci, 2006, 51: 1103-1112.
[23] Rudic JS, Poropat G, Krstic MN, et al. Hormone replacement for osteoporosis in women with primary biliary cirrhosis. Cochrane Database Syst Rev, 2011, 7: CD009146.
[24] Cowley SM, Hoare S, Mosselman S, et al. Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem, 1997, 272: 19858-19862.
[25] Lammert C,Nguyen DL,Juran BD,et al. Questionnaire based assessment of risk factors for primary biliary cirrhosis. Dig L Dis,2013,45: 589-594.
[26] Wang L, Li QM, DU HH, et al. Correlation study of estrogen receptor with peripheral blood cytokines and serum markers in primary biliarycirrhosis patients. Zhonghua Gan Zang Bing Za Zhi, 2012, 20: 336-339.
[27] Axon A,May FE,Gaughan LE,et al. Tartrazine and sunset yellow are xenoestrogens in a new screening assay to identify modulators of human oestrogen receptor transcriptional activity. Toxicology,2012,298: 40-51.
[28] Leask A.CCN2: a bona fide target for anti-fibrotic drug intervention. J Cell Commun Signal,2011,5: 131-133.
[29] Cheng L,Yang Z,Wang X,et al. Suppression of estrogen receptor transcriptional activity by connective tissue growth factor. PLoS One,2011,6: e20028.
[30] 韩聚强, 徐小洁, 叶棋浓. 结缔组织生长因子在雌激素信号通路参与肝纤维化发生中的作用. 临床肝胆病杂志, 2012, 28:71-73.
[31] Takeuchi Y, Ikeda F, Fujioka SI, et al. Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractoryresponse to ursodeoxycholic acid. Gastroenterol Hepatol, 2011, 26: 1395-1401.
[32] Lee TP,Chiang BL. Sex differences in spontaneous versus induced animal models of autoimmun. Autoimmunity Rev,2012,11: A422-A429.
[33] Zhang Y, Chen WZ, Shi JM. Effect of estrogen receptor alpha gene polymorphism on the variations of T lymphocyte subsets and its related cell factors in female patients with primary cholestasis cirrhosis. Zhonghua Gan Zang Bing Za Zhi, 2010, 18: 740-744.
[34] 李飞跃, 王倍, 郭枫. 雌激素α受体基因多态性对原发性胆汁性肝硬化Th1、Th2类细胞因子表达的影响. 亚太传统医药, 2013, 9: 7-9.
[35] 张嫣,陈伟忠,王伟民. 雌激素受体α基因多态性对女性原发性胆汁淤积性肝硬化患者T细胞亚群及其相关细胞因子变化影响的研究. 中华临床医师杂志, 2010, 4:954-961.
[36] Yang L, Zhang H, Jiang YF, et al. Association of estrogen receptor gene polymorphisms and primary biliary cirrhosis in a chinesepopulation: A case-control study. Chinese Med J(Engl), 2015, 128: 3088-3014.
[37] Matsushima H, Mori T, Ito F, et al. Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer. Oncotarget, 2016, 7: 34131-34148.
[38] Harada K, Yuko K, Sato Y, et al. Significance of oestrogen-related receptor γon biliary epithelial cells in the pathogenesis of primary biliary cirrhosis. J Clin Pathol, 2014, 67: 566-572.
[39] 刘英华, 何宁, 姜淑卿, 等. 雌激素相关受体α与雌激素受体α通路相关性研究. 中华肿瘤防治杂志,2013, 20: 1306-1309.
[40] Mirebeau-Prunier D, Le Pennec S, Jacques C, et al. Estrogen-related receptor alpha and PGC-1-related coactivator constitute a novel complexmediating the biogenesis of functional mitochondria. FEBS J, 2010, 277: 713-725.
[41] Harada K, Kakuda Y, Sato Y, et al. Alteration of energy metabolism in the pathogenesis of bile duct lesions in primary biliary cirrhosis. J Clin Pathol, 2014, 67:396-402. |
